Bacterial therapy in the treatment of colon cancer

Recent research by scientists at Lanzhou University in Gansu Province, Northwest China, shows that the probiotic bacterium limosilactobacillus fermentum GR-3, derived from a traditional local fermented food, has the ability to promote apoptosis (programmed cell death) in colon tumor cells and inhibit their growth.

The probiotic bacterium limosilactobacillus fermentum GR-3 may inhibit tumors in mice. Photo: NATURE

Professor Li Xiangkai, the lead researcher, explained that probiotic bacteria such as Lactobacillus GR-3 can specifically target the tumor environment while also regulating the gut microbiota.

The research team successfully isolated Lactobacillus GR-3, a bacterial strain with potent antioxidant properties. Based on these findings, the team explored the potential of Lactobacillus GR-3 in preventing colon cancer through its effects on the gut microbiota and the host's immune system.

The results showed that Lactobacillus GR-3 significantly reduced the growth of colon tumors in mice and demonstrated a positive therapeutic effect.

HUY QUOC

Source: https://www.sggp.org.vn/lieu-phap-vi-khuan-trong-dieu-tri-ung-thu-dai-trang-post758466.html